Home » Topics » Regulatory

Regulatory
RSS

MacroChem's erectile dysfunction therapy moves to phase I/II in U.S.

May 24, 1996

Lovastatin potential for use in post-transplant patients

May 24, 1996

Transdermal scopolamine studied in hypertensive patients

May 24, 1996

Crixivan pediatric formulation in development

May 24, 1996

Amlexanox approvable in U.S.

May 24, 1996

Propecia NDA filing slated for late 1996

May 24, 1996

Zaprinast claimed for treatment of renal failure

May 17, 1996

FK-409 claimed as portal hypertension Rx

May 17, 1996

Pentoxifylline claimed for treating cold symptoms

May 17, 1996

Seven new uses for raloxifene appear in patent literature

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...